EE537 How Good Are Cost-Effectiveness Model Predictions When Compared to Longer Follow-up Data? An Example of Nivolumab Studies in the First-Line Gastro-Oesophageal Setting
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.802
https://www.valueinhealthjournal.com/article/S1098-3015(23)03932-3/fulltext
Title :
EE537 How Good Are Cost-Effectiveness Model Predictions When Compared to Longer Follow-up Data? An Example of Nivolumab Studies in the First-Line Gastro-Oesophageal Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03932-3&doi=10.1016/j.jval.2023.09.802
First page :
Section Title :
Open access? :
No
Section Order :
10289